Total Payments
$39,001
2024 Payments
$330.82
Companies
18
Transactions
79
Medicare Patients
3,142
Medicare Billing
$456,467
Payment Breakdown by Category
Consulting$26,188 (67.1%)
Travel$9,985 (25.6%)
Food & Beverage$1,569 (4.0%)
Other$1,260 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,188 | 13 | 67.1% |
| Travel and Lodging | $9,985 | 12 | 25.6% |
| Food and Beverage | $1,569 | 52 | 4.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,260 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus Corporation | $25,845 | 19 | $0 (2022) |
| Lumendi LLC | $7,793 | 7 | $0 (2019) |
| Gyrus ACMI, Inc. | $4,055 | 12 | $0 (2018) |
| Ethicon US, LLC | $523.78 | 12 | $0 (2024) |
| Intuitive Surgical, Inc. | $344.70 | 9 | $0 (2021) |
| Medtronic, Inc. | $80.69 | 1 | $0 (2024) |
| Braintree Laboratories, Inc. | $50.89 | 2 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $48.05 | 3 | $0 (2023) |
| Covidien LP | $47.75 | 3 | $0 (2018) |
| Smith+Nephew, Inc. | $44.94 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.82 | 7 | Ethicon US, LLC ($205.19) |
| 2023 | $77.56 | 5 | Ethicon US, LLC ($45.93) |
| 2022 | $660.24 | 2 | Olympus Corporation ($630.00) |
| 2021 | $1,397 | 6 | Olympus Corporation ($1,260) |
| 2020 | $857.45 | 2 | Olympus Corporation ($840.00) |
| 2019 | $20,396 | 15 | Olympus Corporation ($20,143) |
| 2018 | $8,139 | 23 | Gyrus ACMI, Inc. ($3,574) |
| 2017 | $7,143 | 19 | Lumendi LLC ($5,216) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply), STRAVIX PL, OASIS | Food and Beverage | In-kind items and services | $44.94 | General |
| Category: Other Advanced Wound Management | ||||||
| 09/03/2024 | Ethicon US, LLC | Harmonic (Device), Enseal | Food and Beverage | In-kind items and services | $61.00 | General |
| Category: Energy | ||||||
| 06/25/2024 | Ethicon US, LLC | Enseal (Device) | Food and Beverage | In-kind items and services | $85.10 | General |
| Category: Energy | ||||||
| 06/25/2024 | Ethicon US, LLC | Enseal (Device) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Energy | ||||||
| 03/13/2024 | Ethicon US, LLC | Enseal (Device), Echelon Flex, Harmonic | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Energy | ||||||
| 01/29/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $80.69 | General |
| Category: Gastrointestinal AI | ||||||
| 01/08/2024 | Ethicon US, LLC | Enseal (Device) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Energy | ||||||
| 11/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/23/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Gastroenterology | ||||||
| 08/01/2023 | Ethicon US, LLC | Echelon Flex (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Endo-Mechanical | ||||||
| 03/29/2023 | Ethicon US, LLC | DERMABOND PRINEO (Device) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Wound Closure | ||||||
| 03/21/2023 | Ethicon US, LLC | Enseal (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Energy | ||||||
| 05/23/2022 | Olympus Corporation | — | Consulting Fee | Cash or cash equivalent | $630.00 | General |
| 05/12/2022 | Johnson & Johnson Health Care Systems Inc. | Enseal X1 (Device) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Energy | ||||||
| 11/30/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $37.19 | General |
| Category: SURGERY | ||||||
| 10/14/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Gastroenterology | ||||||
| 07/21/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $52.59 | General |
| Category: SURGERY | ||||||
| 04/19/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: GI COLON PREP | ||||||
| 03/11/2021 | Olympus Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $840.00 | General |
| 03/11/2021 | Olympus Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $420.00 | General |
| 04/20/2020 | Olympus Corporation | — | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| 03/09/2020 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 11/21/2019 | Ethicon US, LLC | Echelon Powered Circular (Device) | Food and Beverage | In-kind items and services | $69.30 | General |
| Category: Endo-Mechanical | ||||||
| 11/20/2019 | Ethicon US, LLC | Echelon Powered Circular (Device) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Endo-Mechanical | ||||||
| 05/15/2019 | Olympus Corporation | — | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 855 | 1,021 | $504,950 | $134,595 |
| 2022 | 12 | 851 | 953 | $507,505 | $126,060 |
| 2021 | 16 | 871 | 992 | $465,090 | $123,727 |
| 2020 | 13 | 565 | 674 | $283,575 | $72,085 |
Total Patients
3,142
Total Services
3,640
Medicare Billing
$456,467
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 46500 | Injection of hemorrhoid | Office | 2023 | 53 | 91 | $36,400 | $24,257 | 66.6% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 37 | 90 | $45,000 | $21,509 | 47.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 252 | 252 | $50,400 | $20,141 | 40.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 86 | 86 | $103,200 | $16,637 | 16.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 79 | 81 | $121,500 | $14,326 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 112 | $16,800 | $7,818 | 46.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 30 | 30 | $36,000 | $5,719 | 15.9% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 60 | 62 | $12,100 | $5,706 | 47.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 100 | $12,500 | $4,639 | 37.1% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $20,800 | $3,136 | 15.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 47 | $9,400 | $2,994 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $5,200 | $2,795 | 53.8% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Office | 2023 | 12 | 13 | $4,550 | $2,106 | 46.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $16,800 | $1,573 | 9.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $14,300 | $1,240 | 8.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 118 | 118 | $141,600 | $23,271 | 16.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 106 | 107 | $160,500 | $22,838 | 14.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 256 | 256 | $51,200 | $19,842 | 38.8% |
| 46500 | Injection of hemorrhoid | Office | 2022 | 45 | 68 | $27,200 | $18,462 | 67.9% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 27 | 56 | $28,000 | $13,172 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 140 | $21,000 | $8,849 | 42.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 24 | 24 | $28,800 | $4,745 | 16.5% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 51 | 51 | $6,430 | $4,647 | 72.3% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Office | 2022 | 20 | 20 | $7,000 | $3,016 | 43.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 45 | $9,000 | $2,665 | 29.6% |
About Dr. David Zebley, MD
Dr. David Zebley, MD is a Colon & Rectal Surgery healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780689232.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Zebley, MD has received a total of $39,001 in payments from pharmaceutical and medical device companies, with $330.82 received in 2024. These payments were reported across 79 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($26,188).
As a Medicare-enrolled provider, Zebley has provided services to 3,142 Medicare beneficiaries, totaling 3,640 services with total Medicare billing of $456,467. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Colon & Rectal Surgery
- Location Abington, PA
- Active Since 06/20/2005
- Last Updated 07/13/2010
- Taxonomy Code 208C00000X
- Entity Type Individual
- NPI Number 1780689232
Products in Payments
- DiLumen (Device) $7,793
- PK (Device) $3,574
- Not Applicable $1,050
- Da Vinci Surgical System (Device) $344.70
- ENSEAL Product Family (Device) $186.41
- Enseal (Device) $160.57
- Echelon Powered Circular (Device) $86.25
- GI GENIUS (Device) $80.69
- Harmonic (Device) $61.00
- GRAFIX PL (Medical Supply) $44.94
- SPY Technology (Device) $41.62
- GATTEX (Drug) $36.79
- SUTAB (Drug) $33.44
- XIFAXAN (Drug) $30.26
- Enseal X1 (Device) $30.24
- OFIRMEV (Drug) $18.24
- UCERIS FOAM (Drug) $17.79
- MOTOFEN (Drug) $17.45
- Echelon Flex (Device) $16.54
- INTERSTIM (Device) $15.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.